ATE323684T1 - Verfahren und zusammensetzungen unter verwendung von chinazolinonen - Google Patents
Verfahren und zusammensetzungen unter verwendung von chinazolinonenInfo
- Publication number
- ATE323684T1 ATE323684T1 AT01932769T AT01932769T ATE323684T1 AT E323684 T1 ATE323684 T1 AT E323684T1 AT 01932769 T AT01932769 T AT 01932769T AT 01932769 T AT01932769 T AT 01932769T AT E323684 T1 ATE323684 T1 AT E323684T1
- Authority
- AT
- Austria
- Prior art keywords
- quinazolinones
- compositions
- methods
- associatged
- formulae
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21310400P | 2000-06-21 | 2000-06-21 | |
US09/699,047 US6545004B1 (en) | 1999-10-27 | 2000-10-24 | Methods and compositions utilizing quinazolinones |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE323684T1 true ATE323684T1 (de) | 2006-05-15 |
Family
ID=26907773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01932769T ATE323684T1 (de) | 2000-06-21 | 2001-04-27 | Verfahren und zusammensetzungen unter verwendung von chinazolinonen |
Country Status (24)
Country | Link |
---|---|
US (7) | US6545004B1 (de) |
EP (2) | EP1707563A3 (de) |
JP (1) | JP4854906B2 (de) |
KR (1) | KR100847788B1 (de) |
CN (1) | CN1229353C (de) |
AT (1) | ATE323684T1 (de) |
AU (3) | AU2001259270B2 (de) |
BR (1) | BR0111898A (de) |
CA (1) | CA2413426C (de) |
CY (1) | CY1105070T1 (de) |
CZ (1) | CZ303007B6 (de) |
DE (1) | DE60118921T2 (de) |
DK (1) | DK1296959T3 (de) |
ES (1) | ES2262649T3 (de) |
HK (1) | HK1053837A1 (de) |
HU (1) | HU229078B1 (de) |
IL (1) | IL153554A (de) |
MX (1) | MXPA02012627A (de) |
NO (1) | NO324440B1 (de) |
NZ (1) | NZ523233A (de) |
PL (1) | PL204525B1 (de) |
PT (1) | PT1296959E (de) |
SI (1) | SI1296959T1 (de) |
WO (1) | WO2001098278A1 (de) |
Families Citing this family (121)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4965825A (en) | 1981-11-03 | 1990-10-23 | The Personalized Mass Media Corporation | Signal processing apparatus and methods |
US7831204B1 (en) | 1981-11-03 | 2010-11-09 | Personalized Media Communications, Llc | Signal processing apparatus and methods |
DE60031285T2 (de) | 1999-08-27 | 2007-08-30 | Chemocentryx Inc., Mountain View | Heterozyclische verbindungen und verfahren zur modulierung von cxcr3 funktion |
US20070021493A1 (en) * | 1999-09-16 | 2007-01-25 | Curis, Inc. | Mediators of hedgehog signaling pathways, compositions and uses related thereto |
US7230000B1 (en) * | 1999-10-27 | 2007-06-12 | Cytokinetics, Incorporated | Methods and compositions utilizing quinazolinones |
US7671200B2 (en) * | 1999-10-27 | 2010-03-02 | Cytokinetics, Inc. | Quinazolinone KSP inhibitors |
KR20050049562A (ko) * | 1999-10-27 | 2005-05-25 | 싸이토키네틱스, 인코포레이티드 | 퀴나졸리논을 사용하는 방법 및 조성물 |
US6545004B1 (en) * | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
NZ526622A (en) | 2000-12-11 | 2006-07-28 | Amgen Sf Llc | CXCR3 antagonists |
EP1360180A1 (de) * | 2001-01-19 | 2003-11-12 | Cytokinetics, Inc. | Phenothiazinkinesininhibitoren |
US6794379B2 (en) | 2001-06-06 | 2004-09-21 | Tularik Inc. | CXCR3 antagonists |
MXPA03011933A (es) | 2001-06-22 | 2004-03-26 | Pfizer Prod Inc | Composiciones farmaceuticas de farmacos y polimeros acidos neutralizados. |
EP1425016B1 (de) * | 2001-09-05 | 2010-06-02 | Minerva Biotechnologies Corporation | Zusammensetzungen und deren verwendung zur behandlung von krebs |
WO2003039460A2 (en) | 2001-11-07 | 2003-05-15 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
AU2002366103A1 (en) * | 2001-11-19 | 2003-06-10 | Iconix Pharmaceuticals, Inc. | Modulators of rho c activity |
EP1847534B9 (de) * | 2001-12-11 | 2012-03-21 | Kyowa Hakko Kirin Co., Ltd. | Thiadiazolin-Derivate zur Behandlung von Krebs |
JP2005529076A (ja) * | 2002-02-15 | 2005-09-29 | サイトキネティクス・インコーポレーテッド | キナゾリノンの合成 |
EP1521746B1 (de) | 2002-03-07 | 2011-04-27 | X-Ceptor Therapeutics, Inc. | Chinazolinon modulatoren von nukleinrezeptoren |
US6924376B2 (en) | 2002-04-17 | 2005-08-02 | Cytokinetics, Inc. | Compounds, compositions and methods |
AU2003270015A1 (en) * | 2002-05-09 | 2003-12-02 | Cytokinetics, Inc. | Compounds, compositions, and methods |
NZ537076A (en) * | 2002-05-09 | 2007-06-29 | Cytokinetics Inc | Pyrimidinone compounds, compositions and methods |
JP2005536475A (ja) * | 2002-05-23 | 2005-12-02 | サイトキネティクス・インコーポレーテッド | 化合物、組成物、および方法 |
EP1556357A4 (de) * | 2002-06-14 | 2006-09-13 | Cytokinetics Inc | Verbindungen, zusammensetzungen und verfahren |
JP2005533119A (ja) * | 2002-07-17 | 2005-11-04 | サイトキネティクス・インコーポレーテッド | 化合物、組成物、及び方法 |
EP1537089A4 (de) * | 2002-07-23 | 2008-04-16 | Cytokinetics Inc | Verbindungen, zusammenstellungen und verfahren |
JP2005536553A (ja) * | 2002-08-21 | 2005-12-02 | サイトキネティクス・インコーポレーテッド | 化合物、組成物および方法 |
EP1554265A4 (de) * | 2002-09-13 | 2008-05-07 | Cytokinetics Inc | Verbindungen, zusammensetzungen und verfahren |
JP2006501306A (ja) * | 2002-09-30 | 2006-01-12 | サイトキネティクス・インコーポレーテッド | 化合物、組成物および方法 |
US7358262B2 (en) | 2003-01-29 | 2008-04-15 | Whitehead Institute For Biomedical Research | Identification of genotype-selective anti-tumor agents |
WO2006018628A1 (en) * | 2003-03-07 | 2006-02-23 | Astrazeneca Ab | Enantiomers of selected fused pyrimidones and uses in the treatment and preventi on of cancer |
SE0300627D0 (sv) * | 2003-03-07 | 2003-03-07 | Astrazeneca Ab | Novel fused heterocycles and uses therof |
SI1601673T1 (sl) * | 2003-03-07 | 2009-10-31 | Astrazeneca Ab | Kondenzirani heterocikli in njihove uporabe |
JP2006523232A (ja) * | 2003-04-10 | 2006-10-12 | サイトキネティクス・インコーポレーテッド | 化合物、組成物、および方法 |
WO2004092123A2 (en) * | 2003-04-10 | 2004-10-28 | Microbia, Inc. | Inhibitors of fungal invasion |
US7851635B2 (en) | 2003-04-18 | 2010-12-14 | Kyowa Hakko Kirin Co., Ltd. | Mitotic kinesin inhibitor |
EP1620092A4 (de) * | 2003-05-07 | 2008-04-16 | Cytokinetics Inc | Verbindungen, zusammensetzungen und verfahren |
WO2004103282A2 (en) * | 2003-05-15 | 2004-12-02 | Cytokinetics, Inc. | Compounds, compositions and methods |
US7345046B2 (en) * | 2003-05-30 | 2008-03-18 | Chiron Corporation | Heteroaryl-fused pyrimidinyl compounds as anticancer agents |
WO2004111024A1 (ja) * | 2003-06-10 | 2004-12-23 | Kyowa Hakko Kogyo Co., Ltd. | チアジアゾリン誘導体 |
US7326711B2 (en) * | 2003-06-20 | 2008-02-05 | Chiron Corporation | Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents |
AU2004264533B2 (en) * | 2003-08-15 | 2009-01-22 | Merck Sharp & Dohme Corp. | Mitotic kinesin inhibitors |
JP2007507539A (ja) * | 2003-10-06 | 2007-03-29 | サイトキネティクス・インコーポレーテッド | 化合物、組成物及び方法 |
US20070112044A1 (en) * | 2003-10-10 | 2007-05-17 | Kyowa Hakko Kogyo Co., Ltd. | Thiadiazoline derivative |
WO2005041888A2 (en) * | 2003-11-03 | 2005-05-12 | Cytokinetics, Inc. | Pyrimidin-4-one compounds, compositions and methods |
EP1680420A4 (de) * | 2003-11-07 | 2008-09-24 | Cytokinetics Inc | Verbindungen, zusammensetzungen und verfahren |
ATE538103T1 (de) * | 2003-11-25 | 2012-01-15 | Novartis Ag | Chinazolinonverbindungen als antikrebsmittel |
US7439254B2 (en) | 2003-12-08 | 2008-10-21 | Cytokinetics, Inc. | Compounds, compositions, and methods |
US7662581B1 (en) | 2003-12-18 | 2010-02-16 | Novartis Vaccines And Diagnostics, Inc. | Eg5 co-crystals |
EP1696927A4 (de) * | 2003-12-19 | 2007-10-31 | Merck & Co Inc | Inhibitoren von mitotischem kinesin |
EP1697331A4 (de) * | 2003-12-19 | 2010-08-04 | Merck Sharp & Dohme | Inhibitoren von mitotischem kinesin |
WO2005061518A1 (en) * | 2003-12-19 | 2005-07-07 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
BRPI0508183B8 (pt) | 2004-04-02 | 2021-05-25 | Prana Biotechnology Ltd | compostos neurologicamente ativos, seus usos, composição farmacêutica ou veterinária e processos para preparação dos mesmos |
US7795448B2 (en) * | 2004-05-06 | 2010-09-14 | Cytokinetics, Incorporated | Imidazoyl-benzamide anti-cancer agents |
US7618981B2 (en) * | 2004-05-06 | 2009-11-17 | Cytokinetics, Inc. | Imidazopyridinyl-benzamide anti-cancer agents |
US7504413B2 (en) * | 2004-05-06 | 2009-03-17 | Cytokinetics, Inc. | N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases |
JP2008502721A (ja) * | 2004-05-21 | 2008-01-31 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド | 分裂キネシンインヒビターとしての置換キノリン誘導体 |
US20050282834A1 (en) * | 2004-06-09 | 2005-12-22 | Fady Malik | Compositions, devices and methods for treating cardiovascular disease |
AU2005258135B2 (en) | 2004-06-18 | 2011-09-22 | Novartis Vaccines And Diagnostics Inc. | N- (1- (1-benzyl -4-phenyl-1H-imidazol-2-YL) -2,2-dymethylpropyl) benzamide derivatives and related compounds as kinesin spindle protein (KSP) inhibitors for the treatment of cancer |
US7271271B2 (en) | 2004-06-28 | 2007-09-18 | Amgen Sf, Llc | Imidazolo-related compounds, compositions and methods for their use |
US7939538B2 (en) * | 2004-06-28 | 2011-05-10 | Amgen Inc. | Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases |
US7375102B2 (en) | 2004-06-28 | 2008-05-20 | Amgen Sf, Llc | Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their use |
MX2007000809A (es) * | 2004-07-22 | 2007-03-21 | Astrazeneca Ab | Pirimidonas fusionadas utiles en el tratamiento y la prevencion de cancer. |
US20060041128A1 (en) * | 2004-08-18 | 2006-02-23 | Astrazeneca Ab | Selected fused heterocyclics and uses thereof |
CN101027309B (zh) * | 2004-08-18 | 2010-10-27 | 阿斯利康(瑞典)有限公司 | 所选择的稠合嘧啶酮的对映体和在治疗和预防癌症中的用途 |
EP1786265A4 (de) * | 2004-08-30 | 2009-08-19 | Smithkline Beecham Corp | Neue zusammensetzungen und behandlungsverfahren |
WO2007053135A1 (en) * | 2004-09-14 | 2007-05-10 | Minerva Biotechnologies Corporation | Methods for diagnosis and treatment of cancer |
KR20070072598A (ko) * | 2004-10-19 | 2007-07-04 | 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 | 인돌 및 벤지미다졸 유도체 |
US7449486B2 (en) * | 2004-10-19 | 2008-11-11 | Array Biopharma Inc. | Mitotic kinesin inhibitors and methods of use thereof |
WO2006060737A2 (en) * | 2004-12-03 | 2006-06-08 | Takeda San Diego, Inc. | Mitotic kinesin inhibitors |
ES2409686T3 (es) | 2005-01-25 | 2013-06-27 | Prolexys Pharmaceuticals, Inc. | Derivados de quinoxalina como agentes antitumorales |
US20070161644A1 (en) * | 2005-01-25 | 2007-07-12 | Stockwell Brent R | Erastin analogs and uses thereof |
KR20070114822A (ko) * | 2005-03-22 | 2007-12-04 | 교와 핫꼬 고교 가부시끼가이샤 | 조혈기 종양 치료제 |
AU2006225636A1 (en) * | 2005-03-22 | 2006-09-28 | Fujifilm Corporation | Therapeutic agent for solid tumor |
DE102005024017A1 (de) * | 2005-05-25 | 2006-11-30 | Merck Patent Gmbh | Chinazolinone |
US7910611B2 (en) * | 2005-06-24 | 2011-03-22 | Kyowa Hakko Kirin Co., Ltd. | Therapeutic agent for restenosis |
MY147188A (en) * | 2005-08-09 | 2012-11-14 | Novartis Ag | Substituted imidazole compounds as ksp inhibitors |
AU2006294835B2 (en) * | 2005-09-26 | 2011-05-26 | Merck Sharp & Dohme Corp. | N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators |
DE102006002065B4 (de) * | 2006-01-16 | 2007-11-29 | Infineon Technologies Austria Ag | Kompensationsbauelement mit reduziertem und einstellbarem Einschaltwiderstand |
GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
WO2007149476A2 (en) * | 2006-06-19 | 2007-12-27 | Trustees Of Columbia University In The City Of New York | Assays for non-apoptotic cell death and uses thereof |
EP2044222A4 (de) * | 2006-07-27 | 2010-03-03 | Hspa1a als marker für sensitivität gegen ksp-hemmer | |
US8173629B2 (en) | 2006-09-22 | 2012-05-08 | Merck Sharp & Dohme Corp. | Method of treatment using fatty acid synthesis inhibitors |
AU2007303846B2 (en) * | 2006-10-04 | 2011-03-10 | Pfizer Products Inc. | Pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as calcium receptor antagonists |
US8883790B2 (en) | 2006-10-12 | 2014-11-11 | Astex Therapeutics Limited | Pharmaceutical combinations |
JP5528806B2 (ja) | 2006-10-12 | 2014-06-25 | アステックス、セラピューティックス、リミテッド | 複合薬剤 |
US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
GEP20125389B (en) * | 2006-11-13 | 2012-01-25 | Novartis Ag | Substituted pyrazole and triazole compounds as ksp inhibitors |
EP2106399A2 (de) * | 2007-01-05 | 2009-10-07 | Novartis AG | Imidazolderivate als kinesin-spindelprotein-hemmer (eg-5) |
JP4611444B2 (ja) | 2007-01-10 | 2011-01-12 | イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー | ポリ(adp−リボース)ポリメラーゼ(parp)阻害剤としてのアミド置換インダゾール |
CA2679659C (en) | 2007-03-01 | 2016-01-19 | Novartis Ag | Pim kinase inhibitors and methods of their use |
JP5378362B2 (ja) | 2007-05-21 | 2013-12-25 | ノバルティス アーゲー | Csf−1r阻害剤、組成物および使用方法 |
US8232285B2 (en) * | 2007-06-22 | 2012-07-31 | Arqule, Inc. | Quinazolinone compounds and methods of use thereof |
US20110123486A1 (en) * | 2007-06-25 | 2011-05-26 | Prolexys Pharmaceuticals, Inc. | Methods of treating multiple myeloma and resistant cancers |
EP3103791B1 (de) | 2007-06-27 | 2018-01-31 | Merck Sharp & Dohme Corp. | 4-carboxybenzylamino-derivate als histondeacetylase-hemmer |
JP5462862B2 (ja) * | 2008-04-22 | 2014-04-02 | サントル・ナショナル・ドゥ・ラ・ルシェルシュ・シャンティフィク | メラニン形成を阻害するためのKif13A阻害剤およびAP−1阻害剤の使用 |
JP6043285B2 (ja) | 2010-08-02 | 2016-12-14 | サーナ・セラピューティクス・インコーポレイテッドSirna Therapeutics,Inc. | 低分子干渉核酸(siNA)を用いたカテニン(カドヘリン結合型タンパク質)β1(CTNNB1)遺伝子発現のRNA干渉媒介性阻害 |
EP2606134B1 (de) | 2010-08-17 | 2019-04-10 | Sirna Therapeutics, Inc. | Rna-interferenz-vermittelte hemmung der hepatitis b-virus (hbv)-genexpression mittels kurzer interferierender nukleinsäure (sina) |
EP2608669B1 (de) | 2010-08-23 | 2016-06-22 | Merck Sharp & Dohme Corp. | Neue pyrazolo-[1,5-a-]pyrimidinderivate als mtor-hemmer |
EP2615916B1 (de) | 2010-09-16 | 2017-01-04 | Merck Sharp & Dohme Corp. | Kondensierte pyrazolderivate als neue erk-hemmer |
US8927559B2 (en) * | 2010-10-11 | 2015-01-06 | Merck Sharp & Dohme Corp. | Quinazolinone-type compounds as CRTH2 antagonists |
EP3327125B1 (de) | 2010-10-29 | 2020-08-05 | Sirna Therapeutics, Inc. | Rna-interferenz-vermittelte inhibition von genexpression unter verwendung kurzer interferierender nukleinsäure (sina) |
EP2455456A1 (de) | 2010-11-22 | 2012-05-23 | Institut Curie | Verwendung von Kinesininhibitoren bei der Behandlung von HIV-Infektion und Verfahren zu deren Abtastung |
CA2833009A1 (en) | 2011-04-21 | 2012-10-26 | Merck Sharp & Dohme Corp. | Insulin-like growth factor-1 receptor inhibitors |
US8940742B2 (en) * | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
EP3919620A1 (de) | 2012-05-02 | 2021-12-08 | Sirna Therapeutics, Inc. | Zusammensetzungen mit kurzer interferierender nukleinsäure (sina) |
PT2935246T (pt) | 2012-12-21 | 2018-10-10 | Gilead Calistoga Llc | Inibidores de fosfatidilinositol 3-quinase de quinazolinona ou isoquinolinona |
EP2941426B1 (de) | 2012-12-21 | 2018-06-13 | Gilead Calistoga LLC | Substituierte pyrimidin-aminoalkyl-chinazolone als phosphatidylinositol-3-kinase-hemmer |
CA2915129C (en) | 2013-06-14 | 2021-07-27 | Gilead Sciences, Inc. | Phosphatidylinositol 3-kinase inhibitors |
EP3041938A1 (de) | 2013-09-03 | 2016-07-13 | Moderna Therapeutics, Inc. | Kreisförmige polynukleotide |
WO2015051241A1 (en) * | 2013-10-04 | 2015-04-09 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
PE20160685A1 (es) | 2013-10-04 | 2016-07-23 | Infinity Pharmaceuticals Inc | Compuestos heterociclicos y usos de los mismos |
JP6701088B2 (ja) | 2014-03-19 | 2020-05-27 | インフィニティー ファーマシューティカルズ, インコーポレイテッド | Pi3k−ガンマ媒介障害の治療で使用するための複素環式化合物 |
JO3589B1 (ar) | 2014-08-06 | 2020-07-05 | Novartis Ag | مثبطات كيناز البروتين c وطرق استخداماتها |
US9708348B2 (en) | 2014-10-03 | 2017-07-18 | Infinity Pharmaceuticals, Inc. | Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof |
CA2998469A1 (en) | 2015-09-14 | 2017-03-23 | Infinity Pharmaceuticals, Inc. | Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same |
US10759806B2 (en) | 2016-03-17 | 2020-09-01 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors |
WO2017214269A1 (en) | 2016-06-08 | 2017-12-14 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
TW201813963A (zh) | 2016-09-23 | 2018-04-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
TW201815787A (zh) | 2016-09-23 | 2018-05-01 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
TW201825465A (zh) | 2016-09-23 | 2018-07-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
WO2023203254A2 (en) * | 2022-04-22 | 2023-10-26 | Fundamental Pharma Gmbh | Effective means to modulate nmda receptor-mediated toxicity |
Family Cites Families (138)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1249281B (de) | 1963-05-18 | |||
US3320124A (en) | 1964-07-20 | 1967-05-16 | American Cyanamid Co | Method for treating coccidiosis with quinazolinones |
US3846549A (en) | 1966-09-03 | 1974-11-05 | Boehringer Sohn Ingelheim | Pharmaceutical compositions containing an n-(1-bicyclic aryl-propyl -2)-n-phenyl-piperazine |
BG16042A3 (bg) | 1968-11-12 | 1972-05-20 | Nans Ott | Метод за получаване на нови 2(1н)-хиназолинони |
US3962244A (en) | 1971-01-23 | 1976-06-08 | Hoechst Aktiengesellschaft | Benzene sulfonyl ureas |
US3740442A (en) | 1972-01-14 | 1973-06-19 | Sandoz Ag | 2-isopropylaminobenzophenones in treating inflammation |
US4011324A (en) * | 1976-01-20 | 1977-03-08 | Pfizer Inc. | Esters and amides of pyrimido[4,5-b]quinolin-4(3H)-one-2-carboxylic acids as antiulcer agents |
EP0009008A3 (de) | 1978-09-08 | 1980-05-14 | Ciba-Geigy Ag | Cephalosporinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate |
US4281127A (en) | 1979-07-09 | 1981-07-28 | Hoffmann-La Roche Inc. | Trans-3-(4-oxo-4H-quinazolin-3-yl)-2-propenoic acid derivatives |
DE3177311D1 (de) * | 1980-08-30 | 1994-06-09 | Hoechst Ag | Aminosäurederivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung. |
AU543928B2 (en) | 1981-01-16 | 1985-05-09 | Masayuki Ishikawa | 4(311)-quinazolinone derivatives |
EP0090068A1 (de) | 1982-03-31 | 1983-10-05 | Hans Wenner | Münzautomat für Zeitungen, Zeitschriften, Lebensmittel oder andere Waren |
GB8524663D0 (en) | 1985-10-07 | 1985-11-13 | Fujisawa Pharmaceutical Co | Quinazoline derivatives |
DE3609598A1 (de) | 1986-03-21 | 1987-10-01 | Hoechst Ag | 2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung |
GB8607683D0 (en) | 1986-03-27 | 1986-04-30 | Ici Plc | Anti-tumor agents |
US5187167A (en) | 1986-03-27 | 1993-02-16 | Imperial Chemical Industries Plc | Pharmaceutical compositions comprising quinazolin-4-one derivatives |
US4670560A (en) * | 1986-04-28 | 1987-06-02 | Ortho Pharmaceutical Corporation | Thienopyrimidine-2,4-dione derivatives and intermediates thereof |
US4729996A (en) | 1986-05-29 | 1988-03-08 | Harbor Branch Oceanographic Institution, Inc. | Antitumor compositions and their methods of use |
DE3721855A1 (de) | 1987-03-12 | 1988-09-22 | Merck Patent Gmbh | Aminosaeurederivate |
GB8707053D0 (en) | 1987-03-25 | 1987-04-29 | Ici Plc | Anti-tumour agents |
US4866084A (en) | 1987-07-17 | 1989-09-12 | Harbor Branch Oceanographic Institution, Inc. | Topsentin compounds effective against viruses and certain tumors |
US4808590A (en) | 1987-07-17 | 1989-02-28 | Harbor Branch Oceanographic Institution, Inc. | Antiviral, antitumor and antifungal compositions and their methods of use |
JPS6430768A (en) * | 1987-07-28 | 1989-02-01 | Toshiba Corp | Thermal head |
US5756450A (en) | 1987-09-15 | 1998-05-26 | Novartis Corporation | Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms |
US4857530A (en) | 1987-11-03 | 1989-08-15 | Warner-Lambert Company | Substituted quinazolinones as anticancer agents |
GB8820129D0 (en) | 1988-08-24 | 1988-09-28 | Schering Agrochemicals Ltd | Fungicides |
GB8827820D0 (en) | 1988-11-29 | 1988-12-29 | Janssen Pharmaceutica Nv | (1h-azol-1-ylmethyl)substituted quinoline derivatives |
GB8827988D0 (en) | 1988-11-30 | 1989-01-05 | Smith Kline French Lab | Chemical compounds |
US4970226A (en) | 1989-10-03 | 1990-11-13 | Harbor Branch Oceanographic Institution, Inc. | Bis-indole imidazole compounds which are useful antitumor and antimicrobial agents |
US5264439A (en) | 1990-02-13 | 1993-11-23 | Merck & Co., Inc. | Quinazolinone, triazolinone and pyrimidinone angiotensin II antagonists incorporating a substituted benzyl element |
IL98167A0 (en) | 1990-05-30 | 1992-06-21 | Ici Plc | Anti-tumour quinazoline derivatives,processes for their preparation and pharmaceutical compositions comprising them |
FR2665159B1 (fr) * | 1990-07-24 | 1992-11-13 | Rhone Poulenc Sante | Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent. |
EP0481614A1 (de) | 1990-10-01 | 1992-04-22 | Merck & Co. Inc. | Substituierte Pyridopyrimidinone und verwandte Heterocyclen als Angiotensin-II-Antagoniste |
NL9100023A (nl) * | 1991-01-09 | 1992-08-03 | Crown Gear Bv | Slijpschijf voor het vervaardigen van kroonwielen, alsmede werkwijze voor het vervaardigen van een dergelijke slijpschijf. |
GB9105771D0 (en) | 1991-03-19 | 1991-05-01 | Cancer Res Inst Royal | Anti-cancer compounds |
US5714493A (en) | 1991-05-10 | 1998-02-03 | Rhone-Poulenc Rorer Pharmaceuticals, Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
US5316906A (en) | 1991-08-23 | 1994-05-31 | Molecular Probes, Inc. | Enzymatic analysis using substrates that yield fluorescent precipitates |
US5204354A (en) | 1992-02-14 | 1993-04-20 | Merck & Co., Inc. | Substituted quinazolinones as neurotensin antagonists useful in the treatment of CNS disorders |
CZ286194B6 (cs) | 1992-03-12 | 2000-02-16 | Smithkline Beecham P.L.C. | Kondenzované indolové deriváty, způsob jejich výroby, farmaceutické prostředky s jejich obsahem a použití derivátů pro výrobu farmaceutických prostředků |
GB9205907D0 (en) | 1992-03-18 | 1992-04-29 | Cancer Res Inst Royal | Anti-cancer compounds |
US5430148A (en) | 1992-03-31 | 1995-07-04 | Agouron Pharmaceuticals, Inc. | Antiproliferative quinazolines |
GB9220571D0 (en) | 1992-09-30 | 1992-11-11 | Ici Plc | Quinazoline derivatives |
US5817662A (en) | 1992-11-09 | 1998-10-06 | Cell Therapeutics, Inc. | Substituted amino alkyl compounds |
US5804584A (en) | 1992-11-16 | 1998-09-08 | Cell Therapeutics, Inc. | Therapeutic compounds containing a monocyclic five- to six- membered ring structure having one to two nitrogen atoms |
AU6087894A (en) | 1993-01-14 | 1994-08-15 | Cell Therapeutics, Inc. | Acetal or ketal substituted therapeutic compounds |
WO1994016704A1 (en) | 1993-01-19 | 1994-08-04 | Cell Therapeutics, Inc. | Oxime-substituted therapeutic compounds |
US5574057A (en) | 1993-02-03 | 1996-11-12 | University Of Utah Research Foundation | Naamidine A extracted from sea sponges and methods for its use as an anti-tumor agent |
US5401745A (en) | 1993-03-19 | 1995-03-28 | Merck & Co., Inc. | Quinazolinones substituted with phenoxyphenylacetic acid derivatives |
US5837703A (en) | 1993-03-31 | 1998-11-17 | Cell Therapeutics, Inc. | Amino-alcohol substituted cyclic compounds |
US5342944A (en) | 1993-07-19 | 1994-08-30 | American Cyanamid Company | Process for the preparation of 2-alkyl-3,5,6,7- or 8-substituted-4(3H)-quinazolinones |
US20020198326A1 (en) | 1993-11-12 | 2002-12-26 | Taizo Aoyama | Polyolefin resin composition |
CA2113229C (en) | 1994-01-11 | 1999-04-20 | Mark Pines | Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof |
AU1831395A (en) | 1994-01-14 | 1995-08-01 | Cell Therapeutics, Inc. | Method for treating diseases mediated by cellular proliferation in response to pdgf, egf, fgf and vegf |
WO1995022546A1 (en) | 1994-02-18 | 1995-08-24 | Cell Therapeutics, Inc. | Intracellular signalling mediators |
WO1995024190A2 (en) | 1994-03-07 | 1995-09-14 | Sugen, Inc. | Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof |
GB9404485D0 (en) | 1994-03-09 | 1994-04-20 | Cancer Res Campaign Tech | Benzamide analogues |
US5807861A (en) | 1994-03-24 | 1998-09-15 | Cell Therapeutics, Inc. | Amine substituted xanthinyl compounds |
US5801182A (en) | 1994-03-24 | 1998-09-01 | Cell Therapeutics, Inc. | Amine substituted compounds |
US5756502A (en) | 1994-08-08 | 1998-05-26 | Warner-Lambert Company | Quinazolinone derivatives as cholyecystokinin (CCK) ligands |
JPH09165385A (ja) * | 1994-08-26 | 1997-06-24 | Kyowa Hakko Kogyo Co Ltd | キナゾリン誘導体 |
IL110831A (en) | 1994-08-31 | 1998-12-27 | Hadasit Med Res Service | Pharmaceutical compositions containing quinazolinone derivatives for preventing restenosis |
US5891879A (en) | 1994-08-31 | 1999-04-06 | Hadasit Medical Research Services & Development Co., Inc. | Quinazolinone-containing pharmaceutical compositions and methods for the use thereof |
IL112125A (en) | 1994-12-22 | 1998-02-08 | Hadasit Med Res Service | Quinazolinone-containing pharmaceutical compositions |
US5753664A (en) | 1995-03-16 | 1998-05-19 | Takeda Chemical Industries, Ltd. | Heterocyclic compounds, their production and use |
EP0735143B1 (de) * | 1995-03-28 | 1998-11-18 | Tanabe Seiyaku Co., Ltd. | Verfahren zur Herstellung von D-Aminosäuren |
US6245768B1 (en) | 1995-06-05 | 2001-06-12 | Neurogen Corporation | 1-(N′-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dopamine receptor subtype specific ligands |
US5747498A (en) | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
WO1997008153A1 (fr) | 1995-08-30 | 1997-03-06 | Otsuka Pharmaceutical Factory, Inc. | Procede de production de derives de quinazolin-4-one |
AU4858596A (en) | 1995-09-15 | 1997-04-01 | Torrey Pines Institute For Molecular Studies | Synthesis of quinazolinone libraries |
US5783577A (en) | 1995-09-15 | 1998-07-21 | Trega Biosciences, Inc. | Synthesis of quinazolinone libraries and derivatives thereof |
DE19546918A1 (de) | 1995-12-15 | 1997-06-19 | Bayer Ag | Bicyclische Heterocyclen |
DE19615262A1 (de) | 1996-04-18 | 1997-10-23 | Bayer Ag | Heteroverknüpfte Phenylglycinolamide |
ATE242232T1 (de) | 1996-05-15 | 2003-06-15 | Pfizer | 2,3,6-trisubstituierte 4(3h)-chinazolinone |
US6008010A (en) | 1996-11-01 | 1999-12-28 | University Of Pittsburgh | Method and apparatus for holding cells |
EP0946095A1 (de) * | 1996-12-17 | 1999-10-06 | E.I. Du Pont De Nemours And Company | Fungizide chinazolinone |
US5852024A (en) | 1997-02-11 | 1998-12-22 | Hadasit | Treatment and prevention of adhesions |
US6028075A (en) | 1997-02-11 | 2000-02-22 | Pines; Mark | Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies |
US5948775A (en) | 1997-03-19 | 1999-09-07 | American Home Products Corporation | 2- or 3-(substitutedaminoalkoxyphenyl)quinazolin-4-ones |
US6060479A (en) | 1997-06-09 | 2000-05-09 | Pfizer Inc | Quinazoline-4-one AMPA antagonists |
ES2245015T3 (es) | 1997-06-09 | 2005-12-16 | Pfizer Products Inc. | Quinazolin-4-onas como antagonistas de ampa. |
US6627755B1 (en) | 1997-06-09 | 2003-09-30 | Pfizer Inc | Quinazolin-4-one AMPA antagonists |
US5939421A (en) | 1997-07-01 | 1999-08-17 | Signal Pharmaceuticals, Inc. | Quinazoline analogs and related compounds and methods for treating inflammatory conditions |
DE69842109D1 (de) | 1997-08-21 | 2011-03-10 | Shiseido Co Ltd | Chinazolin-4-on Derivate, deren Herstellung und deren Verwendung als Haarwuchsmittel oder in äusserlich anzuwendenden Hautpflegemitteln |
JP2934628B2 (ja) * | 1997-08-21 | 1999-08-16 | 株式会社資生堂 | キナゾリノン誘導体及び養毛剤、皮膚外用剤 |
IL125950A0 (en) | 1997-09-05 | 1999-04-11 | Pfizer Prod Inc | Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy |
AU2107199A (en) * | 1998-01-08 | 1999-07-26 | Regents Of The University Of California, The | Kinesin motor modulators derived from the marine sponge (adocia) |
US6214879B1 (en) * | 1998-03-24 | 2001-04-10 | Virginia Commonwealth University | Allosteric inhibitors of pyruvate kinase |
WO2000007017A2 (en) | 1998-07-27 | 2000-02-10 | President And Fellows Of Harvard College | Method of high-throughput screening |
US6596497B1 (en) * | 1999-03-17 | 2003-07-22 | New York Blood Center, Inc. | Screening of antiviral compounds targeted to the HIV-1 gp41 core structure |
DE60031285T2 (de) | 1999-08-27 | 2007-08-30 | Chemocentryx Inc., Mountain View | Heterozyclische verbindungen und verfahren zur modulierung von cxcr3 funktion |
US6156758A (en) | 1999-09-08 | 2000-12-05 | Isis Pharmaceuticals, Inc. | Antibacterial quinazoline compounds |
AU780846B2 (en) | 1999-09-16 | 2005-04-21 | Curis, Inc. | Mediators of hedgehog signaling pathways, compositions and uses related thereto |
KR20020047185A (ko) | 1999-09-28 | 2002-06-21 | 플레믹 크리스티안 | 퀴나졸리논 |
CA2385921A1 (en) | 1999-09-28 | 2001-04-05 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Quinazolinones |
AU7839100A (en) | 1999-10-01 | 2001-05-10 | Advanced Medicine, Inc. | Quinazolinones and analogues and their use as local anesthetics |
US6545004B1 (en) | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
US7230000B1 (en) * | 1999-10-27 | 2007-06-12 | Cytokinetics, Incorporated | Methods and compositions utilizing quinazolinones |
KR20050049562A (ko) * | 1999-10-27 | 2005-05-25 | 싸이토키네틱스, 인코포레이티드 | 퀴나졸리논을 사용하는 방법 및 조성물 |
US6380205B1 (en) | 1999-10-29 | 2002-04-30 | Merck & Co., Inc. | 2-cyclohexyl quinazoline NMDA/NR2B antagonists |
US6476041B1 (en) * | 1999-10-29 | 2002-11-05 | Merck & Co., Inc. | 1,4 substituted piperidinyl NMDA/NR2B antagonists |
US6495561B2 (en) * | 1999-10-29 | 2002-12-17 | Merck & Co., Inc. | 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists |
AR026748A1 (es) | 1999-12-08 | 2003-02-26 | Vertex Pharma | Un compuesto inhibidor de caspasas, una composicion farmaceutica que lo comprende, un metodo para la sintesis del mismo y un compuesto intermediario paradicha sintesis |
ATE348382T1 (de) | 2000-01-13 | 2007-01-15 | Koninkl Philips Electronics Nv | Verfahren zum schutz des komprimierten inhaltes nach trennung von originaler quelle |
ES2159488B1 (es) | 2000-03-07 | 2002-04-16 | Uriach & Cia Sa J | Procedimiento para la preparacion de derivados de pirimidona con actividad antifungica. |
US7115653B2 (en) | 2000-03-30 | 2006-10-03 | Curis, Inc. | Small organic molecule regulators of cell proliferation |
US6613798B1 (en) | 2000-03-30 | 2003-09-02 | Curis, Inc. | Small organic molecule regulators of cell proliferation |
ATE305786T1 (de) | 2000-03-30 | 2005-10-15 | Curis Inc | Kleine organische moleküle als regulatoren der zellproliferation |
AU5566701A (en) | 2000-04-25 | 2001-11-07 | Icos Corp | Inhibitors of human phosphatidyl-inositol 3-kinase delta |
US20020165221A1 (en) | 2000-10-13 | 2002-11-07 | Baxter Anthony David | Mediators of hedgehog signaling pathways, compositions and uses related thereto |
AUPR201600A0 (en) | 2000-12-11 | 2001-01-11 | Fujisawa Pharmaceutical Co., Ltd. | Quinazolinone derivative |
NZ526622A (en) | 2000-12-11 | 2006-07-28 | Amgen Sf Llc | CXCR3 antagonists |
WO2002081467A1 (en) * | 2001-04-09 | 2002-10-17 | Ortho-Mcneil Pharmaceutical, Inc. | Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
WO2002085909A1 (en) * | 2001-04-20 | 2002-10-31 | Vertex Pharmaceuticals Incorporated | 9-deazaguanine derivatives as inhibitors of gsk-3 |
US7365199B2 (en) * | 2001-04-20 | 2008-04-29 | Fujifilm Corporation | Dye-forming coupler, silver halide photographic light-sensitive material, and azomethine dye compound |
US6794379B2 (en) | 2001-06-06 | 2004-09-21 | Tularik Inc. | CXCR3 antagonists |
US6936842B2 (en) * | 2001-06-27 | 2005-08-30 | Applied Materials, Inc. | Method and apparatus for process monitoring |
US20030220338A1 (en) * | 2001-07-16 | 2003-11-27 | Watkins Will J. | Fungal efflux pump inhibitors |
US6596723B1 (en) * | 2001-07-16 | 2003-07-22 | Essential Therapeutics, Inc. | Fungal efflux pump inhibitors |
US20030144350A1 (en) * | 2001-07-20 | 2003-07-31 | Adipogenix, Inc. | Fat accumulation-modulation compounds |
US20030119834A1 (en) * | 2001-09-05 | 2003-06-26 | Bamdad Cynthia C. | Compositions and methods of treatment of cancer |
EP1425016B1 (de) * | 2001-09-05 | 2010-06-02 | Minerva Biotechnologies Corporation | Zusammensetzungen und deren verwendung zur behandlung von krebs |
AU2002366103A1 (en) * | 2001-11-19 | 2003-06-10 | Iconix Pharmaceuticals, Inc. | Modulators of rho c activity |
AU2002346471A1 (en) | 2001-11-20 | 2003-06-10 | Cytokinetics, Inc. | Process for the racemization of chiral quinazolinones |
JP2005529076A (ja) | 2002-02-15 | 2005-09-29 | サイトキネティクス・インコーポレーテッド | キナゾリノンの合成 |
US7074805B2 (en) * | 2002-02-20 | 2006-07-11 | Abbott Laboratories | Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
US20030158188A1 (en) * | 2002-02-20 | 2003-08-21 | Chih-Hung Lee | Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
EP1513534A2 (de) * | 2002-04-04 | 2005-03-16 | Cv Therapeutics, Inc. | Verbindungen zur erhöhung der abca-1-expression zur behandlung der koronaren herzkrankheit und atherosklerose |
AU2003270015A1 (en) | 2002-05-09 | 2003-12-02 | Cytokinetics, Inc. | Compounds, compositions, and methods |
NZ537076A (en) | 2002-05-09 | 2007-06-29 | Cytokinetics Inc | Pyrimidinone compounds, compositions and methods |
JP2005536475A (ja) | 2002-05-23 | 2005-12-02 | サイトキネティクス・インコーポレーテッド | 化合物、組成物、および方法 |
EP1556357A4 (de) | 2002-06-14 | 2006-09-13 | Cytokinetics Inc | Verbindungen, zusammensetzungen und verfahren |
US20040092561A1 (en) * | 2002-11-07 | 2004-05-13 | Thomas Ruckle | Azolidinone-vinyl fused -benzene derivatives |
EP1537089A4 (de) | 2002-07-23 | 2008-04-16 | Cytokinetics Inc | Verbindungen, zusammenstellungen und verfahren |
JP2005536553A (ja) | 2002-08-21 | 2005-12-02 | サイトキネティクス・インコーポレーテッド | 化合物、組成物および方法 |
EP1663237B1 (de) * | 2003-09-10 | 2013-06-19 | Icagen, Inc. | Kondensierte ringheterozyklen als kaliumkanalmodulatoren |
ATE538103T1 (de) * | 2003-11-25 | 2012-01-15 | Novartis Ag | Chinazolinonverbindungen als antikrebsmittel |
US20050152940A1 (en) * | 2003-12-23 | 2005-07-14 | Medtronic Vascular, Inc. | Medical devices to treat or inhibit restenosis |
US20050282834A1 (en) * | 2004-06-09 | 2005-12-22 | Fady Malik | Compositions, devices and methods for treating cardiovascular disease |
-
2000
- 2000-10-24 US US09/699,047 patent/US6545004B1/en not_active Expired - Lifetime
- 2000-11-28 US US09/724,941 patent/US6831085B1/en not_active Expired - Lifetime
- 2000-11-28 US US09/724,897 patent/US7105668B1/en not_active Expired - Fee Related
- 2000-11-28 US US09/724,713 patent/US6630479B1/en not_active Expired - Lifetime
- 2000-11-28 US US09/724,644 patent/US6562831B1/en not_active Expired - Fee Related
-
2001
- 2001-04-27 ES ES01932769T patent/ES2262649T3/es not_active Expired - Lifetime
- 2001-04-27 AU AU2001259270A patent/AU2001259270B2/en not_active Ceased
- 2001-04-27 AT AT01932769T patent/ATE323684T1/de active
- 2001-04-27 PL PL358412A patent/PL204525B1/pl not_active IP Right Cessation
- 2001-04-27 US US10/312,323 patent/US20040023996A1/en not_active Abandoned
- 2001-04-27 EP EP06075276A patent/EP1707563A3/de not_active Withdrawn
- 2001-04-27 JP JP2002504234A patent/JP4854906B2/ja not_active Expired - Fee Related
- 2001-04-27 BR BR0111898-6A patent/BR0111898A/pt not_active Application Discontinuation
- 2001-04-27 CZ CZ20024178A patent/CZ303007B6/cs not_active IP Right Cessation
- 2001-04-27 HU HU0301201A patent/HU229078B1/hu not_active IP Right Cessation
- 2001-04-27 PT PT01932769T patent/PT1296959E/pt unknown
- 2001-04-27 WO PCT/US2001/013901 patent/WO2001098278A1/en active IP Right Grant
- 2001-04-27 EP EP01932769A patent/EP1296959B1/de not_active Expired - Lifetime
- 2001-04-27 KR KR1020027017358A patent/KR100847788B1/ko not_active IP Right Cessation
- 2001-04-27 AU AU5927001A patent/AU5927001A/xx active Pending
- 2001-04-27 DK DK01932769T patent/DK1296959T3/da active
- 2001-04-27 SI SI200130539T patent/SI1296959T1/sl unknown
- 2001-04-27 IL IL153554A patent/IL153554A/en active IP Right Grant
- 2001-04-27 CN CNB018115829A patent/CN1229353C/zh not_active Expired - Lifetime
- 2001-04-27 CA CA2413426A patent/CA2413426C/en not_active Expired - Fee Related
- 2001-04-27 MX MXPA02012627A patent/MXPA02012627A/es active IP Right Grant
- 2001-04-27 DE DE60118921T patent/DE60118921T2/de not_active Expired - Lifetime
- 2001-04-27 NZ NZ523233A patent/NZ523233A/en not_active IP Right Cessation
-
2002
- 2002-12-20 NO NO20026172A patent/NO324440B1/no not_active IP Right Cessation
-
2003
- 2003-08-26 HK HK03106128A patent/HK1053837A1/xx unknown
-
2004
- 2004-07-20 US US10/893,929 patent/US7294634B2/en not_active Expired - Lifetime
-
2006
- 2006-07-07 CY CY20061100942T patent/CY1105070T1/el unknown
- 2006-11-16 AU AU2006236024A patent/AU2006236024A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60118921D1 (de) | Verfahren und Zusammensetzungen unter Verwendung von Chinazolinonen | |
ATE327224T1 (de) | Chinazolinone benutzende verfahren und zusammenstellungen | |
WO2003103575A3 (en) | COMPOUNDS, COMPOSITIONS AND METHODS | |
SE9900100D0 (sv) | New compounds | |
WO2004018058A3 (en) | Compounds, compositions, and methods | |
WO2003094839A8 (en) | Pyrimidinone compounds, compositions and methods | |
MY140169A (en) | Compounds, compositions, and methods | |
WO2004009036A3 (en) | Compounds compositions and methods | |
DE60326248D1 (de) | Verbindungen, zusammensetzungen und verfahren zur behandlung von zellulären proliferativen erkrankungen | |
WO2004032840A3 (en) | Compounds, compositions, and methods | |
WO2004034972A3 (en) | Compounds, compositions, and methods | |
WO2004064741A3 (en) | Compounds, compositions, and methods | |
WO2005046588A3 (en) | Compounds, compositions, and methods | |
WO2005042697A3 (en) | Compounds, compositions and methods | |
WO2004032879A3 (en) | Compounds, compositions, and methods | |
WO2004024086A3 (en) | Compounds, compositions and methods | |
WO2005062847A3 (en) | Compounds, compositions and methods | |
DE502005005474D1 (de) | Verwendung von speziellen formylierten chinoliniumderivaten in kombination mit aminosubtituierten pyrimidinderivaten und mindestens einem weiteren primären oder sekundären, aromatischen amin | |
DE60226522D1 (de) | Wortmannin-Analoge und Verfahren zu deren Verwendung | |
ECSP982587A (es) | Derivados de piridina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1296959 Country of ref document: EP |